Michael Jerman

Michael Jerman

Director/Board Member at INHIBITOR THERAPEUTICS, INC.

Net worth: 2 311 $ as of 2024-04-29

40 year
Consumer Services
Health Technology
Commercial Services

Profile

Michael Jerman is an Independent Director at Inhibitor Therapeutics, Inc., a Director at MIRA Pharmaceuticals, Inc., and an Independent Director at Telomir Pharmaceuticals, Inc. He is also the Managing Partner at Hollywell Partners LLC.
Previously, he worked as a Director at PricewaterhouseCoopers LLP from 2007 to 2019.
Mr. Jerman holds an MBA from the University of Oxford, an undergraduate degree from the University of South Florida, and a graduate degree from The University of Tampa, Inc.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-28 30,411 ( 0.02% ) 2 311 $ 2024-04-29
2024-03-31 0 ( -.--% ) - $ 2024-04-29

Michael Jerman active positions

CompaniesPositionStart
INHIBITOR THERAPEUTICS, INC. Director/Board Member 2023-05-23
MIRA PHARMACEUTICALS, INC. Director/Board Member 2023-11-13
All active positions of Michael Jerman

Former positions of Michael Jerman

CompaniesPositionEnd
Director/Board Member 2019-07-31
See the detail of Michael Jerman's experience

Training of Michael Jerman

University of South Florida Undergraduate Degree
The University of Tampa, Inc. Graduate Degree
University of Oxford Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Jerman's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
INHIBITOR THERAPEUTICS, INC.

Health Technology

MIRA PHARMACEUTICALS, INC.

Health Technology

Private companies1

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Michael Jerman
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW